http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
메이지일본과 ‘문명전쟁’의 정치학 * 청일 러일 전쟁기 아리가 나가오(有賀長雄)의 사상을 중심으로
최민혁(Choe, Min-Hyeok) 일본사학회 2019 일본역사연구 Vol.49 No.-
It is the subject which has been researched in various fields that, during the Meiji period, Japan succeeded to emerge into full membership in the international society which was controlled by western powers at the time. This paper takes the approach of the study of the history of political thought to understand the rise of Japan during the Meiji period. In order to do that, this paper will focus on Ariga Nagao who was one of the pioneers of the study of international law and history of diplomacy. Ariga argued a war, even without a declaration, is a fully legitimate act, since it is the expression of the ‘free will’ of independent states. Ariga’s pro-war theory of international law was affected by Lorenzo von Stein who was a scholar of Staatswissenschaft which means the sciences of the state in German. In Ariga’s theory, military intervention by a powerful nation to a weaker one is justified with this magic word of the ‘free will’. At the same time, Ariga strongly states that, if Japan is to become one of the ‘civilized countries’, it is required to follow the diplomatic custom of them: And there was no exception during the war time. He rather considers the war as the most effective way to prove how ‘civilized’ Japan is. During the Sino-Japanese and Russo-Japanese wars, he accompanied a army for the purpose of proving that the Japanese army is conducting a war in accordance with the ‘civilized custom . In conclusion, Ariga shows two different seemingly contradictory arguments: One is the absolutization of national sovereignty, which even justifies ‘imperialism’, and the other is the observance of the ‘civilized custom’ of the international community. A ‘civilized empire’ would be an appropriate definition to describe Japan s diplomatic ideals of the time.
최원혁,박유정,홍일철,이한철,박세훈,최성철,이효락,정인경,정재훈,민용기,이명식,이문규,김광원,김원석 대한내분비학회 2001 Endocrinology and metabolism Vol.16 No.2
MEN1 is characterized by the combined occurrence of tumors of the parathyroids, pancreatic islet cells and the anterior pituitary. Pancreatic islet cell tumors occur in 40% of MEN1 patients. Pancreatic polypeptidomas occur most commonly but they are asymptomatic. Gastrinomas are the second most common type. VIPomas are rare and there has been no report of a case in Korea so far. We encountered a case of pancreatic VIPoma in MEN Type I. A 49 year old man was referred from his local hospital presenting with a sudden onset of an explosive watery diarrhea of 3 months duration. Abnormal findings in his blood chemistry were hypercalcemia and hypokalemia. The ^99mTc-sestamibi sintigraphy showed an increased uptake in right lower parathyroid gland. Abdominal CT demonstrated a mass of 6×4 ㎝ in tail of the pancreas and multiple lesions in both hepatic lobes. Serum levels of VIP hormones were elevated. Subtotal parathyroidectomy and subtotal pancreatectomy were done. Postoperatively his symptoms were improved transiently, however the patient showed repetitive attacks of watery diarrhea. So in order to palliate his symptoms, an RF ablation of the metastatic liver masses was performed. After that therapy his clinical symptoms were reduced dramatically. Unfortunately, the patients condition worsened again. Despite of continuous octreotide therapy, interferon and two courses of combination chemotherapy, the hepatic metastases failed to regress and the patient died 10 months after the diagnosis of a metastatic VIPoma. This is the first report of pancreatic VIPoma in MEN type I in Korea
( Jae Min Park ),( Won Hyeok Choe ),( Jeong Han Kim ),( So Young Kwon ),( Byung Chul Yoo ) 대한간암학회 2021 대한간암학회지 Vol.21 No.2
Background/Aims: Because hepatitis B virus (HBV) replication has been known to play an important role in cancer recurrence after curative treatment of HBV-related hepatocellular carcinoma (HCC), we examined whether treatment based on nucleos(t)ide analogues (NAs) might decrease the recurrence rate and improve patient survival. Methods: The retrospective cohort study enrolled 73 patients with chronic hepatitis B who were treated with transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) with curative intent for HCC. Among those, 30 and 43 patients were treated with tenofovir disoproxil fumarate (TDF) and entecavir (ETV), respectively. Results: Of the 73 patients, 51 experienced HCC recurrence, and 14 patients were dead during a follow-up of 73±34 months. Multivariate analyses showed that tumor size (hazard ratio [HR], 1.590; 95% confidence-interval [CI], 1.106-2.285; P=0.012) and Child-Pugh class B (vs. class A/non cirrhosis; HR, 5.794; 95% CI, 2.311-14.523; P=0.001) was significantly associated with HCC recurrence, and Child-Pugh class B (HR, 7.357; 95% CI, 2.100-25.777; P=0.002) was an independent unfavorable prognostic factor for survival. During NAs therapy, TDF was superior to ETV for complete viral response at 1 year after the date of combination of TACE and RFA (P=0.016). However, the risks of HCC recurrence and survival were not significantly different between those treated with TDF versus ETV. Conclusions: TDF was superior to ETV for achieving complete viral response. However, the recurrence and mortality after TACE and RFA for HBV-related HCC were not significantly different between patients treated with TDF versus ETV. (J Liver Cancer 2021;21:155-162)
비대상성 간경변이 호전된 간세포암종에서 경동맥화학색전술과 고주파열치료술로 병합치료한 증례
유형민 ( Hyung Min Yu ),최원혁 ( Won Hyeok Choe ),권소영 ( So Young Kwon ),김정한 ( Jeong Han Kim ) 대한간암학회 2014 대한간암학회지 Vol.14 No.2
Case Reports : A Case of Hepatocellular Carcinoma with Improved Decompansated Liver Cirrhosis with Combination Treatment of Transarterial Chemoembolization and Radiofrequency Ablation
최숙근 ( Suk Keun Choe ),정민형 ( Min Hyung Jung ),김대연 ( Dae Yeon Kim ),서대식 ( Dae Sik Seo ),김종혁 ( Jong Hyeok Kim ),김용만 ( Yong Man Kim ),김영탁 ( Young Tak Kim ),남주현 ( Joo Hyun Nam ),목정은 ( Jung Eun Mok ) 대한산부인과학회 2006 Obstetrics & Gynecology Science Vol.49 No.11
Objective: To evaluate the incidence, characteristics, and convalescence times of urinary tract injury after gynecological surgery, total abdominal hysterectomy (TAH), laparoscopic-assisted vaginal hysterectomy (LAVH), total vaginal hysterectomy (VH), radical hysterectomy (RH), and laparoscopic-assisted radical hysterectomy (LRH). Methods: We retrospectively analyzed 109 patients with urinary tract injuries after total hysterectomy from May 1989 to April 2004. During the study period, 18,721 hysterectomies were carried out. Results: The total incidence of urinary tract injury after total hysterectomy was 0.59%, as follows: TAH, 0.55%; LAVH, 0.64%; VH, 0.62%; RH, 0.69%; and LRH, 1.56%. The total incidence of bladder and ureteric injury was, respectively, 0.51 and 0.09%, as follows: TAH, 0.51 and 0.04%; LAVH, 0.57 and 0.07%; VH, 0.62 and 0%; RH, 0.21 and 0.49%; and LRH, 1.79 and 0.89%. There was no significant difference of the incidence of urinary tract injury type of operation with benign findings (P>0.05), but there was significant difference of the incidence of injury between type of operation with benign and malignant findings (P<0.05). The convalescence times were 10.3±8.7 days after bladder injury and 44.4±16.27 days after ureteric injury diagnosed intraoperatively, but 33.3±46.6 days after bladder injury and 69.0±16.4 days after ureteric injury diagnosed postoperatively. There was significant difference between both groups (P<0.05). Conclusion: In this study, total hysterectomy resulted in 0.59% incidence of urinary tract injury and repair of these injuries was successful in all cases. There was no significant difference for incidence of urinary tract injury between types of operation with benign findings, but there was significant difference between types of operation for benign and malignant findings. The convalescence times for intraoperatively recognized injuries were significantly shorter than those for injuries recognized postoperatively. 109, but significant difference between benign and malignant gynecological operations (P<0.05). Tintraoperatively recognized.